054670 Stock Chart & Stats
₩5600.00
₩210.00(3.90%)
―
--
Day’s Range― - ―
52-Week Range₩5,030.00 - ₩7,900.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)32.16K
Market Cap
₩75.65B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)4.8
Beta0.13
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding14,354,920
10 Day Avg. Volume29,728
30 Day Avg. Volume32,162
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
054670 FAQ
What was Daehan Nupharm Co., Ltd.’s price range in the past 12 months?
Daehan Nupharm Co., Ltd. lowest stock price was ₩5030.00 and its highest was ₩7900.00 in the past 12 months.
What is Daehan Nupharm Co., Ltd.’s market cap?
Daehan Nupharm Co., Ltd.’s market cap is ₩75.65B.
When is Daehan Nupharm Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Daehan Nupharm Co., Ltd.’s earnings last quarter?
Daehan Nupharm Co., Ltd. released its earnings results on May 13, 2026. The company reported ₩213.591 earnings per share for the quarter, beating the consensus estimate of N/A by ₩213.591.
Is Daehan Nupharm Co., Ltd. overvalued?
According to Wall Street analysts Daehan Nupharm Co., Ltd.’s price is currently Undervalued.
Does Daehan Nupharm Co., Ltd. pay dividends?
Daehan Nupharm Co., Ltd. does not currently pay dividends.
What is Daehan Nupharm Co., Ltd.’s EPS estimate?
Daehan Nupharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Daehan Nupharm Co., Ltd. have?
Daehan Nupharm Co., Ltd. has 14,354,920 shares outstanding.
What happened to Daehan Nupharm Co., Ltd.’s price movement after its last earnings report?
Daehan Nupharm Co., Ltd. reported an EPS of ₩213.591 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.627%.
Which hedge fund is a major shareholder of Daehan Nupharm Co., Ltd.?
Currently, no hedge funds are holding shares in KR:054670
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sam-A Pharm. Co., Ltd.
―
Osang Healthcare Co. Ltd.
―
iNtRON Biotechnology, Inc.
―
Optipharm Co., Ltd.
―
Enzychem Lifesciences Corp.
―